The HGF/c-MET pathway has emerged as a prime target for cancer pathways and tumorigenesis15 However, despite the clinical therapeutic significance of this pathway, the mechanism by which HGF activates c-MET is not well understood. The gene discussed is MET; the disease is cancer.